# Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients

> **NCT00767546** · PHASE1 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Parkinson Disease
- Parkinsonism
- Seborrheic Dermatitis

## Interventions

- **DRUG:** Botulinum toxin

## Key facts

- **NCT ID:** NCT00767546
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2008-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767546, "Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00767546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*